
OTCQX Best 50
Virtual Investor Conference
OTCQX Best 50
Hosted by Virtual Investor Conferences
March 19th, 2026
Virtual Conference
The 2026 OTCQX Best 50 is out, recognizing a diverse group of companies from 13 countries with market capitalizations ranging from $146M to $289B and more than $60B in U.S. trading volume last year. Congratulations to the companies recognized.
These companies, along with other innovative issuers, have opportunities to engage directly with investors through events like the OTCQX Best 50 Virtual Investor Conference, which brings together public companies and a global audience of individual and institutional investors for a full day of live, online presentations.
All public companies—whether listed on NYSE, Nasdaq, TSX, CSE, ASX, or the OTC Markets—are welcome and encouraged to participate. The conference provides an efficient, accessible venue for issuers to share their story with thousands of investors worldwide.
Through Virtual Investor Conferences, companies can present remotely, reach retail and institutional investors at scale, participate in live Q&A, and extend their visibility through on-demand replays and analytics. The March 19th event will feature executive-level presentations from companies across the AI and technology sectors, including both early-stage innovators and publicly traded issuers.
B2i Digital, Inc. is the Official Marketing Partner of the March 19th: OTCQX Best 50 Virtual Investor Conference. Content about any specific company was provided and approved by that company or available in the public domain. B2i Digital, Inc. has not independently verified the accuracy of the information contained herein. The content contained herein is informational only, and no content contained herein shall be considered an offer to solicit the sale of any security or make a recommendation to purchase a security. B2i Digital is not a broker-dealer or investment adviser. Virtual Investor Conferences is an OTC Markets Group Inc. property.

Virtual Investor Conferences (VIC) provides an interactive forum for publicly traded companies to present directly to investors. Offering real-time engagement solutions, VIC helps companies connect with a global audience of retail and institutional investors.
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
![]()
OTC Markets Group Inc. (OTCQX: OTCM) operates a regulated stock market for the trading of over 12,000 U.S. and global securities. They organize these securities into four markets based on the quality and timeliness of the disclosure and the information which the company provides to investors: OTCQX® Best Market, OTCQB® Venture Market, the OTCIDTM Basic Market, and Pink LimitedTM Market.
The OTC Link® Alternative Trading Systems (ATSs) provide the critical market infrastructure broker-dealers rely on to facilitate trading. This innovative model offers companies more efficient access to the U.S. financial markets.
OTC Link ATS, OTC Link ECN, and OTC Link NQB are each an SEC-regulated ATS, operated by OTC Link LLC, a FINRA and SEC registered broker-dealer, member SIPC.

To view the full events calendar, please follow the button below.
Genvor Inc. (OTCQB: GNVR)
Genvor, Inc. (OTC: GNVR) is a biotechnology company pioneering peptide-based solutions for crop protection and plant health. With a focus on sustainable agriculture, Genvor develops and commercializes biological actives that enhance crop performance, reduce chemical inputs, and support regenerative farming systems. Through its partnerships and technology platforms, Genvor is advancing a new era of natural, science-based crop protection For more information, visit www.genvor.com.
![]()
OS Therapies Incorporated (NYSE American: OSTX)
OS Therapies is a clinical stage oncology company focused on the identification, development, and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The Company is the world leader in listeria-based cancer immunotherapies. OST-HER2, the Company's lead asset, is an immunotherapy leveraging the immune-stimulatory effects of Listeria bacteria to initiate a strong immune response targeting the HER2 protein. OST-HER2 has received Rare Pediatric Disease Designation (RPDD) from the U.S. Food & Drug Administration and Fast-Track and Orphan Drug designations from the U.S. FDA and European Medicines Agency. The Company reported positive data in its Phase 2b clinical trial of OST-HER2 in recurrent, fully resected, lung metastatic osteosarcoma, demonstrating statistically significant benefit in the 12-month event free survival (EFS) primary endpoint of the study. The Company anticipates submitting a Biologics Licensing Application (BLA) to the U.S. FDA for OST-HER2 in osteosarcoma in the First Quarter of 2026 and, if approved, would become eligible to receive a Priority Review Voucher that it could then sell. OST-HER2 has completed a Phase 1 clinical study primarily in breast cancer patients, in addition to showing preclinical efficacy data in various models of breast cancer. OST-HER2 has been conditionally approved by the U.S. Department of Agriculture for the treatment of canines with osteosarcoma.
In addition, OS Therapies is advancing its next-generation Antibody Drug Conjugate (ADC) and Drug Conjugates (DC), known as tunable ADC (tADC), which features tunable, tailored antibody-linker-payload candidates. This platform leverages the Company's proprietary silicone Si-Linker and Conditionally Active Payload (CAP) technology, enabling the delivery of multiple payloads per linker.

Prostatype Genomics AB (OTCQB: PGABF | Nasdaq First North: PROGEN)
Prostatype® is a genetic test available to patients and treating urologists as a complementary decision-making tool when considering treatment or non-treatment of prostate cancer. The test was developed by a research group at Karolinska Institutet and is provided by Prostatype Genomics AB.
Impala Platinum Holdings Ltd. (OTCQX: IMPUF; IMPUY | JSE: IMP)
Impala Platinum Holdings Limited (Implats) is a leading, fully integrated platinum group metals (PGMs) producer. The Group is structured around six mining operations, refining and processing facilities, and a refining business, Impala Refining Services (IRS). Implats operates across three of the world’s most significant PGM-bearing ore bodies: the Bushveld Complex in South Africa, the Great Dyke in Zimbabwe and the Canadian Shield. Its portfolio includes Impala Rustenburg, Zimplats, Marula, Impala Canada, Mimosa and Two Rivers.
Implats contributes approximately 20% to annual global primary PGM production and employs more than 66 000 people. Guided by its purpose, the Group’s vision is to be the most valued and responsible metals producer, creating a better future for its stakeholders. Implats is committed to a value-focused strategy built on developing a portfolio of long-life, low-cost, shallow, mechanised or mechanisable mining assets that can deliver sustainable returns for all its stakeholders through the PGM cycle.
Implats maintains a primary listing on the JSE in South Africa, a secondary listing on South Africa’s A2X, and a level one American Depositary Receipt programme in the United States.
Industry: Platinum Group Metals (PGM) Mining
Luca Mining Corp. (OTCQX: LUCMF| TSXV: LUCA)
Luca Mining Corp. (TSX-V: LUCA, OTCQX: LUCMF, Frankfurt: Z68) is a Canadian mining company with two wholly owned mines located in the prolific Sierra Madre mineralized belt in Mexico. These mines produce gold, copper, zinc, silver, and lead and generate strong cash flow. Both mines have considerable development and resource upside as well as significant exploration potential.
The Company’s Campo Morado Mine hosts VMS-style, polymetallic mineralization within a large land package comprising 121 square kilometres. It is an underground operation, producing zinc, copper, gold, silver, and lead. The mine is located in Guerrero State.
The Tahuehueto Mine is a large property of over 100 square kilometres in Durango State. The project hosts epithermal gold and silver vein-style mineralization. Tahuehueto is a newly constructed underground mining operation producing primarily gold and silver. Luca has successfully commissioned its mill and is now in commercial production at Tahuehueto.
Industry: Gold, copper, silver, zinc, lead
Infineon Technologies AG (OTCQX: IFNNY; IFNNF | FSE: IFX)
Infineon Technologies AG is a global semiconductor leader in power systems and IoT. Infineon drives decarbonization and digitalization with its products and solutions. The Company had around 57,000 employees worldwide (end of September 2025) and generated revenue of about €14.7 billion in the 2025 fiscal year (ending 30 September). Infineon is listed on the Frankfurt Stock Exchange (ticker symbol: IFX) and in the USA on the OTCQX International over-the-counter market (ticker symbol: IFNNY).
Heliostar Metals Ltd. (OTCQX: HSTXF | TSXV: HSTR)
Heliostar Metals is rapidly emerging as the next mid-tier gold producer, driven by a clear strategy and the core tenets of speed, grade, and growth. With two producing mines and four development-stage assets - led by the high-grade Ana Paula Project targeting 2028 production - the company is leveraging near-term cash flow into dilution-free expansion.
Deutsche Lufthansa AG (OTCQX: DLAKF, DLAKY | FSE: LHA)
The Lufthansa Group is a global aviation group with a total of more than 300 subsidiaries and equity investments. The Lufthansa Group is composed of the segments Network Airlines, Eurowings and Aviation Services.
J Sainsbury plc (OTCQX: JSAIY, JSNSF | LSE: SBRY)
Sainsbury's is the second largest grocer in the UK, with 600 supermarkets and more than 850 convenience stores. We’re proud to be part of our communities up and down the country.
Alongside our food business, we are one of the biggest general merchandise and clothing retailers through our family of brands.
We've built market-leading retail media capabilities through our Nectar360 business, powered by our world leading Nectar loyalty platform and coalition of partner brands.
Altius Minerals Corp. (OTCQX: ATUSF | TSX: ALS)
Altius’s strategy is to create per share growth through a diversified portfolio of royalty assets that relate to long life, high margin operations. This strategy further provides shareholders with exposures that are well aligned with global growth trends including increasing electricity-based market share within energy usage, global infrastructure build and refurbishment growth, increased EAF based steelmaking, steadily increasing agricultural fertilizer requirements and the enhanced appetite for financial asset diversification through precious metals ownership. These macro-trends each hold the potential to cause higher demand for many of Altius’s commodity exposures including potash, high purity iron ore, renewable energy, base metals, and gold. In addition, Altius runs a successful Project Generation business that originates mineral projects for sale to developers in exchange for royalties and that has a demonstrated track record of driving outsized direct returns from its overall royalty investment portfolio. Altius has 55,915,754 common shares issued and outstanding that are listed on Canada’s Toronto Stock Exchange. It is a member of both the S&P/TSX Small Cap and S&P/TSX Global Mining Indices and the S&P/TSX Canadian Dividend Aristocrats Index.
Ucore Rare Metals, Inc. (OTCQX: UURAF| TSXV: UCU)
Ucore is focused on rare- and critical-metal resources, extraction, beneficiation, and separation technologies with the potential for production, growth, and scalability. Ucore's vision and plan is to become a leading advanced technology company, providing best-in-class metal separation products and services to the mining and mineral extraction industry. Through strategic partnerships, this plan includes disrupting the People's Republic of China's control of the North American REE supply chain through the near-term development of a heavy and light rare-earth processing facility in the US State of Louisiana, subsequent SMCs in Canada and Alaska and the longer-term development of Ucore's 100% controlled Bokan-Dotson Ridge Rare Heavy REE Project on Prince of Wales Island in Southeast Alaska, USA ("Bokan"). Ucore is listed on the TSXV under the trading symbol "UCU" and in the United States on the OTC Markets' OTCQX® Best Market under the ticker symbol "UURAF."
For further information, please visit www.ucore.com.
Ahold Delhaize (OTCQX: ADRNY; AHODF | AMS: AD)
Ahold Delhaize is a global food retail and e-commerce company headquartered in the Netherlands, operating a portfolio of well-known supermarket brands across the United States and Europe, including Food Lion, Stop & Shop, Giant Food, Hannaford, Delhaize, and Albert Heijn. The company serves millions of customers weekly through thousands of stores and growing digital platforms. Ahold Delhaize focuses on omnichannel grocery retail, combining strong local brands with investments in e-commerce, supply chain automation, and data-driven customer engagement. With a large presence in the U.S. grocery market and diversified European operations, the company generates stable cash flows and is generally viewed by investors as a defensive consumer staples business with opportunities for long-term growth through digital expansion, private-label products, and operational efficiencies.






